David Shaw’s Organon & Co OGN Stock Holding History

David Shaw’s Portfolio OGN Stock Details OGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-38,400	Closed	-$573K	–	4599
2024 Q4	$573K	Hold	38,400	–	–	﹤0.01%	3530
2024 Q3	$735K	Hold	38,400	–	–	﹤0.01%	3478
2024 Q2	$795K	Hold	38,400	–	–	﹤0.01%	3331
2024 Q1	$722K	Sell	38,400 -200,000	-84%	-$3.43M	﹤0.01%	3289
2023 Q4	$3.44M	Buy	+238,400	New	+$3.24M	﹤0.01%	2233
2023 Q3	–	Sell	-35,000	Closed	-$728K	–	4417
2023 Q2	$728K	Buy	+35,000	New	+$761K	﹤0.01%	3249
2022 Q1	–	Sell	-53,850	Closed	-$1.64M	–	5822
2021 Q4	$1.64M	Sell	53,850 -1,000	-2%	-$32.6K	﹤0.01%	3533
2021 Q3	$1.8M	Sell	54,850 -38,000	-41%	-$1.22M	﹤0.01%	3137
2021 Q2	$2.81M	Buy	+92,850	New	+$3.06M	﹤0.01%	2591

Other funds holding OGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return

AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

David Shaw's OGN Position: Q2 2026 in Review

David Shaw reduced its Organon & Co (OGN) stake by 73% in Q2 2026, selling an estimated $23M and leaving 718,753 shares worth $9.73M. The position accounts for ﹤0.01% of the portfolio, ranked #1833.

David Shaw first reported a position in OGN in Q2 2021 and has held it in 14 quarters since. The position peaked at $34.6M in Q2 2021. 627 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

David Shaw held 718,753 shares of Organon & Co worth $9.73M as of Q2 2026.
David Shaw sold 1,925,799 Organon & Co shares in Q2 2026, an estimated $23M.
Organon & Co made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #1833 holding.
David Shaw first reported a position in Organon & Co in Q2 2021 and has held it in 14 quarters since.
David Shaw's Organon & Co position peaked at $34.6M in Q2 2021.
627 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.